parthenolide and Leukemia

parthenolide has been researched along with Leukemia in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alwaseem, H; Fasan, R; Jordan, CT; Li, QY; O'Dwyer, KM; Ponder, J; Tyagi, V1
Gach, K; Janecka, A1
Chin, YE; Fu, GH; Huang, YN; Ye, H; Zeng, Z; Zhang, YC1
Chen, J; Shi, J; Sun, J; Wei, H; Yi, J1
Jordan, CT; Pei, S1
Basheer, A; Datti, A; Gronda, M; Hurren, R; Lin, FH; MacLean, N; Schimmer, AD; Spagnuolo, PA; Wang, X; Wrana, J1
Jordan, CT1
Czyz, M; Duechler, M; Stańczyk, M; Stepnik, M1

Reviews

3 review(s) available for parthenolide and Leukemia

ArticleYear
α-Methylene-γ-lactones as a novel class of anti-leukemic agents.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:5

    Topics: Animals; Antineoplastic Agents; Humans; Lactones; Leukemia; Neoplastic Stem Cells; Plant Extracts; Sesquiterpenes; Sesquiterpenes, Guaiane

2014
How close are we to targeting the leukemia stem cell?
    Best practice & research. Clinical haematology, 2012, Volume: 25, Issue:4

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Drug Delivery Systems; Glutathione; Humans; Leukemia; Neoplastic Stem Cells; Oxidative Stress; Sesquiterpenes

2012
The leukemic stem cell.
    Best practice & research. Clinical haematology, 2007, Volume: 20, Issue:1

    Topics: Antineoplastic Agents; Drug Evaluation, Preclinical; Humans; Leukemia; Neoplastic Stem Cells; Sesquiterpenes; Thiadiazoles

2007

Other Studies

5 other study(ies) available for parthenolide and Leukemia

ArticleYear
Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs.
    Bioorganic & medicinal chemistry, 2016, 09-01, Volume: 24, Issue:17

    Topics: Acylation; Antineoplastic Agents; Bacillus megaterium; Bacterial Proteins; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Escherichia coli; Humans; Leukemia; NADH, NADPH Oxidoreductases; NADPH-Ferrihemoprotein Reductase; Phenylacetates; Sesquiterpenes; Stereoisomerism

2016
The NF-κB p65/miR-23a-27a-24 cluster is a target for leukemia treatment.
    Oncotarget, 2015, Oct-20, Volume: 6, Issue:32

    Topics: Animals; Apoptosis; Base Sequence; Cell Differentiation; Erythropoiesis; HEK293 Cells; Humans; Leukemia; Mice; Mice, Inbred C57BL; MicroRNAs; Molecular Sequence Data; Promoter Regions, Genetic; Sesquiterpenes; Transcription Factor RelA; Up-Regulation

2015
[Effect of parthenolide on leukemia K562 cells and its leukemia stem cells].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2010, Volume: 35, Issue:2

    Topics: Apoptosis; Cell Proliferation; Humans; K562 Cells; Leukemia; Neoplastic Stem Cells; Plant Extracts; Sesquiterpenes

2010
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide's anti-leukemic activity.
    Leukemia, 2013, Volume: 27, Issue:6

    Topics: Cell Line, Tumor; Dipeptidases; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Leukemia; Real-Time Polymerase Chain Reaction; Sesquiterpenes

2013
Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:5

    Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; DNA Fragmentation; Drug Synergism; Flow Cytometry; Glutamate-Cysteine Ligase; Glutathione; Humans; Leukemia; Mice; Microscopy, Fluorescence; NF-kappa B; Oxides; Reactive Oxygen Species; Sesquiterpenes

2008